MENU
ARCT
AS OF
Dec 24 closing price
Price
$6.50
Change
+$0.07 (+1.09%)
Capitalization
184.68M
67 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ARCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Ownership - Who owns Arcturus Therapeutics Holdings?

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
184.68M
P/E Ratio
N/A
Total Cash
180.36M
Projected Growth
N/A
Total Debt
25.99M
Revenue
85.14M
Risk (Beta)
3.39
Dividend Yield
N/A
Total Cash/Share
6.35
Total Debt/Equity
N/A
Revenue/Share
3.14 USD as % of share price

Fundamentals

ARCT
Capitalization
185M
P/E Ratio
N/A
Risk (Beta)
3.39
Dividend Yield
N/A
Total Cash
180M
Total Cash/Share
6.35
Total Debt
26M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.14%
Revenue
85.1M
ROE
N/A
Book Value
225M
P/B Ratio
0.82
Cash Flow
N/A
Earnings
-2.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
7.86
Current Revenue Per Employee
80414.77
Dividends Per Share - Security
N/A
EBITDA
-60.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.43
Shares Held By Institutions
755M
Shares Outstanding - Current
28.4M
Total Liabilities
57.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-61.697
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ARCT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARCT showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ARCT
A.I. Advisor
published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com